Physician profile
Robert Schwartz
NPI 1881685345
$526.29
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $139 · 2021: $55.62 · 2022: $97.71.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $336.33 | 2019-2020 | |
| Merz Pharmaceuticals, LLC | $58.37 | 2021-2022 | |
| Peerless Surgical INC. | $37.13 | 2022 | |
| Abbvie INC. | $22.03 | 2022 | |
| Grt US Holding, INC. | $19.96 | 2021 | |
| Nevro Corp. | $15.84 | 2022 | |
| Otto Bock Healthcare LP | $12.91 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.35 | 2020 | |
| Scilex Pharmaceuticals INC. | $11.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.